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 ABSTRACT 
Few studies have examined HIV-testing decision-making since the South African 
national HIV counseling and testing campaign in 2010-2011 and subsequent 
expansion in antiretroviral therapy (ART) eligibility in 2012.  We describe HIV-testing 
decision-making and pathways to testing among participants in Pathways to Care, a 
cohort study of newly-diagnosed HIV-positive adults in KwaZulu-Natal. Our analysis 
is embedded within a theoretical framework informed by Arthur Kleinman’s work on 
pluralistic healthcare systems, and the concept of diagnostic itineraries (i.e. the 
route taken to HIV testing).  We conducted 26 semi-structured interviews in 2012, 
within one month of participants’ diagnosis. Most (n=22) deferred testing until they 
had developed symptoms, and then often sought recourse in non-biomedical 
settings. Of the eleven symptomatic participants who accessed professional medical 
services prior to testing, only three reported that a healthcare professional had 
offered or recommended an HIV test.  Although ART emerged as an important 
motivator, offering hope of health and normalcy, fear of death and HIV-related 
stigma remained key barriers. Despite national policy changes in testing and 
treatment, health system and individual factors contributed to ongoing high levels of 
late diagnosis of HIV in this study population. Encouraging local health systems to 
direct clients toward HIV testing, and continuing to raise awareness of the benefits 
of routine testing remain important strategies to reduce delayed diagnoses.  
 
 
 
INTRODUCTION 
 The expansion of HIV testing is a core component of UNAIDS’ 90-90-90 strategy to 
establish the majority of those living with HIV on successful antiretroviral therapy 
(ART) (UNAIDS, 2014), with current World Health Organization (WHO) guidelines 
recommending initiation of ART at diagnosis regardless of CD4 count (World Health 
Organisation, 2015).   However, only modest increases in CD4 count at diagnosis 
and/or presentation to care have been achieved in sub-Saharan Africa in recent 
years, with most studies reporting a median CD4 count ≤350 cells/µL among people 
newly-diagnosed with HIV or presenting for care (Hoffman et al., 2014; Lahuerta et 
al., 2014; Lesko, Cole, Zinski, Poole, & Mugavero, 2013; Siedner et al., 2015). In 
KwaZulu-Natal,  South Africa (site of this study), HIV prevalence is 17.4% (Shisana et 
al., 2014). Late HIV diagnosis continues to be a challenge, with a 2010-11 study in 
Durban reporting a median CD4 count at diagnosis of 186 cells/µL (Drain et al., 
2013).   
 
In 2010 the South African government launched a national HIV counseling and 
testing (HCT) campaign that included mass media, opt-out provider-initiated HIV 
testing, and expanded access to testing outside of public clinics (South African 
National AIDS Council (SANAC), 2010). According to government estimates, 13 
million of the targeted 15 million people were tested by April 2011 (Mbengashe, 
2012). Nevertheless, 2012 data revealed that over 40% of men and nearly 30% of 
women had never undergone HIV testing (Maughan-Brown, Lloyd, Bor, & 
Venkataramani, 2016; Shisana et al., 2014), although there was an increase in self-
reported testing between 2010 and 2012 (Maughan-Brown et al., 2016).  
 Qualitative studies of HIV testing in KwaZulu-Natal have highlighted the role of 
stigma, low HIV risk perception, and uncertainty about ART eligibility in explaining  
delay, and the importance of accessing ART in encouraging people to test (Daftary, 
Padayatchi, & Padilla, 2007; Ntsepe et al., 2014; Phakathi, Van Rooyen, Fritz, & 
Richter, 2011; Strauss, Rhodes, & George, 2015). To our knowledge, only one 
qualitative study of HIV-testing behavior has been conducted since the HCT 
campaign, a few months after its launch (Ntsepe et al., 2014). In this paper we 
explore the decision-making process around HIV testing and describe pathways to 
testing (diagnostic itineraries) among adults newly-diagnosed with HIV in KwaZulu-
Natal in 2012.   
METHODS 
Conceptual framework 
Individuals’ decisions about health are embedded within relationships with family, 
peers and the wider community. We draw upon Kleinman’s work on medical 
systems as cultural systems (Kleinman, 1978) to understand the complex local 
“healthcare system” (comprising the professional, popular and folk sectors) in which 
individuals make decisions about their health.   The presence of multiple sectors in 
which people seek healthcare (and may move between) is known as medical 
pluralism.    
 
We use the term diagnostic itinerary to describe the route an individual takes 
through the local healthcare system before undergoing an HIV test, drawing from 
work on therapeutic itineraries (Kibadi et al., 2009; Smith & Mbakwem, 2007), which 
explores the paths individuals follow to manage illness.  This approach, which allows 
us to map the varied, and sometimes complex, journeys individuals make within 
local healthcare systems in pursuit of a diagnosis, can yield important insights into 
healthcare utilization, and the strengths and weaknesses within existing local 
systems (Moshabela, Pronyk, Williams, Schneider, & Lurie, 2011).   
 
Participants and Data  
Data were drawn from 26 semi-structured (qualitative) interviews (SSIs) (13 women, 
13 men), who comprised a sub-sample of participants in Pathways to Engagement in 
HIV Care for Newly-Diagnosed South Africans. This prospective cohort study 
recruited 459 newly-diagnosed HIV-positive women and men from three 
comprehensive public primary healthcare clinics (PHC) in the eThekwini district 
(Durban metropolitan region) of KwaZulu-Natal, South Africa. All three clinics (one 
rural, and two urban - in a former black middle class township and in a small town 
outside Durban) provided a range of primary healthcare services and ART treatment 
in addition to HCT. Eligible participants for the cohort study were aged 18 years or 
older, not referred from antenatal services and not previously diagnosed with HIV.  
Those who tested HIV-positive on the day of recruitment and underwent a 
structured baseline assessment within 30 days of their diagnosis were enrolled in the 
cohort study. Detailed study procedures are described elsewhere (Hoffman et al., 
2016).   
 
Participants for serial SSIs were recruited in April and May 2012 from among those 
enrolling in the cohort. National guidelines at the time defined ART eligibility as 
WHO Stage 4 disease, CD4 ≤200 cells/µL, drug resistant tuberculosis, or CD4 ≤350 
cells/µL if pregnant or diagnosed with tuberculosis (National Department of Health 
Republic of South Africa, 2010). The SSI sub-sample was purposively selected, with a 
target of 10 participants from each of the three study clinics, equally divided 
between women and men. We obtained demographic characteristics and participant 
CD4 count following diagnosis from the structured assessments.  
 
Qualitative data collection 
Experienced interviewers conducted SSIs at a study site near the recruitment clinic 
after participants completed the structured assessment.  Interviews were conducted 
in isiZulu, digitally audio-recorded, and later translated and transcribed verbatim 
into English by native isiZulu speakers. The 45-minute baseline SSI was organized 
around five topic areas: pathways to diagnosis, current care- and support-seeking, 
sexual behavior and fertility intentions, disclosure of HIV-status and management of 
stigma, and psychological well-being and coping.   
Qualitative data analysis 
Interview transcripts were analyzed in NVivo 9.0 (QSR International, 2010). Data 
were reduced by extracting transcript sections that included reference to HIV 
testing. The first author undertook a thematic analysis of the reduced data, following 
grounded theory principles (Pope, Ziebland, & Mays, 2000). Interview extracts were 
initially open-coded inductively. Coded text was then compared across interviews to 
develop broader analytic categories and link core themes. The initial codebook was 
developed by the first author (ST) in discussion with a co-author (SH), who also 
coded five interviews. Coding discrepancies were discussed until consensus was 
reached, and the codebook modified as appropriate. The first author conducted the 
final coding.  
Ethical approval 
Written informed consent was obtained from participants before conducting SSIs. 
Participants were reimbursed R75 (approximately $10 at the time). Procedures were 
approved by the Institutional Review Board of the New York State Psychiatric 
Institute/Department of Psychiatry, Columbia University and the Biomedical 
Research Ethics Committee of the University of KwaZulu-Natal. Approval was also 
granted by the KwaZulu-Natal Department of Health district- and clinic-level 
administrators.   
 
RESULTS 
Participant characteristics 
A comparison of the SSI subsample of 26 participants (13 men, 13 women) and the 
full cohort is shown in Table 1. Within gender, characteristics were similar between 
the two. Overall, the median age of SSI participants was 28 years (range: 20-52 
years) (data not shown). Late diagnosis of HIV was common, with seven (41%) 
reporting a CD4 count at diagnosis below the threshold of ART initiation in South 
Africa at that time (≤200cells/µl).    
 
In the following sections, we refer to illustrative quotes (Box 1) from interviews by 
number and letter (in parentheses). 
Diagnostic itineraries 
The majority of participants (n=19) reported that their most recent HIV test—at 
which they were diagnosed with HIV—was their first ever test. This was the case for 
all men, whereas just over half of women (n=7) reported having had a previous HIV 
test (all negative), one during pregnancy.   
 
All participants identified a precipitating factor in their decision to test.  A minority 
(n=4) were asymptomatic, reporting that their decision was prompted by a new 
sexual relationship. Others talked about witnessing the effects of HIV among friends 
and family, or receiving encouragement by friends who had tested HIV-positive (Box 
1, 1a). 
 
In Figure 1 we reconstruct participants' diagnostic itineraries from accounts given in 
SSIs. The four asymptomatic participants all reported going directly to their primary 
healthcare clinic (PHC) for HIV testing.   
 
Many participants described the importance of “knowing your status,” echoing 
public health discourse on HIV testing. However, there was often a discrepancy 
between reported belief in the importance of “knowing your status” and individual 
testing behavior. The overwhelming majority (n=22) experienced symptoms prior to 
their HIV-positive diagnosis, describing this as the impetus to test (Box 1,1b). 
Participants most commonly reported headaches, weight loss, sweats and 
gastrointestinal symptoms, all of which could indicate HIV-related illness. Of the 22 
who were symptomatic prior to their HIV-positive diagnosis, only three (all male) 
went directly to their PHC for HIV testing (figure 1).  The remaining 19 described 
complex journeys through the pluralistic local healthcare system.   
 
Drawing upon Kleinman's model of “healthcare systems” (1978), we identified four 
sectors in which participants sought diagnostic recourse. We recognize that there is 
pluralism within each of these healthcare sectors, and therefore use these broad 
categories heuristically. The professional sector, comprising private and public sector 
healthcare facilities, was the most commonly accessed source of healthcare, 
followed by the popular sector, encompassing local chemists--some of which offered 
herbal treatments--and self-treatment with over-the-counter and home remedies. 
Some participants described seeking diagnostic or therapeutic guidance from family 
members, which we categorized separately due to its prevalence. Although 
participants described the presence of traditional healers and churches, only two 
described seeking help within the folk sector (Box, 1c). One consulted a family 
member who was an isangoma (Zulu traditional healer who practices divination) 
with no success, having experienced no improvement in symptoms after attending 
his local PHC. The other sought advice about unexplained weight loss from her 
pastor's wife, who encouraged her to test for HIV. 
 
Many interviewees described a process characterized by trial and error, in which 
they attempted to seek a resolution to their symptoms in one healthcare sector. 
When this failed and symptoms persisted, they either attended their PHC for an HIV 
test or attended a second service in a different sector. All participants described 
attending a PHC for an HIV test by their third healthcare sector contact; however, for 
many, their trajectory had delayed HIV testing.   
 
Of note, eleven participants accessed a service in the professional sector with 
symptoms (many indicative of HIV), but only three reported being offered or advised   
HIV testing by healthcare professionals. For example, one participant described 
recurrent episodes of sexually transmitted infection for which he had been treated 
at a local clinic, reportedly never being offered an HIV test (Box 1, 1d).   
  
Other barriers to testing 
As we have already highlighted, the overwhelming majority of participants deferred 
HIV testing until they had physical symptoms. There was a widespread belief among 
participants that there was no need to test for HIV if they were well (Box 1, 2a.i and 
2a.ii). The close coupling of HIV with both symptomatic disease and high-risk sexual 
behaviors contributed to a reluctance to acknowledge HIV risk (Box 1, 2b). Once ill, 
participants pursued multiple therapeutic approaches as discussed previously, with 
only a minority (n=3) immediately seeking an HIV test. For five participants, these 
delays in HIV testing may have reflected poor knowledge about HIV within their 
wider communities (Box 1, 2c). 
 
Another important barrier to testing was fear, with 8 of the 19 participants who had 
never tested before describing fear as the main reason for delaying. Participants 
feared both physical and social consequences of an HIV diagnosis, with many 
commenting upon the enduring association between HIV and death. Participants' 
accounts demonstrated that although HIV-related stigma had declined, it remained 
widespread within their communities. HIV was still seen as a “disgrace,” and 
participants feared that disclosure of their status would lead to gossip and 
discrimination, further discouraging them from testing (Box 1, 2d). 
 
Facilitators of testing  
Sharing a decision to test within an intimate relationship or receiving 
encouragement from family members were identified as important catalysts in HIV- 
testing (Box 1, 3a.i). Although opportunities to suggest HIV testing were sometimes 
missed within healthcare settings, when healthcare professionals did advise testing 
this was also a major impetus (Box 1, 3a.ii). Furthermore, having made the decision 
to test, participants found encouragement and reassurance from staff performing 
pre-test counselling to be important in motivating them to proceed. 
 
Less than half (n=12) of participants reported awareness of the 2010 HCT campaign. 
In general, men more commonly than women cited the campaign (including 
President Zuma's well-publicized HIV test) and other media representations of HIV as 
a motivating factor (Box 1, 3b). 
 
By far the most commonly cited motivation to test for HIV was the knowledge that 
ART was widely and freely available. Twenty-one participants stated that knowing 
that they could access ART if needed influenced their decision to test (Box 1, 3c).  
Despite participants’ concerns about potential side effects, the increasing visibility of 
ART within communities had fostered optimism. Witnessing ART's capacity to 
preserve health served as a powerful demonstration of the importance of testing 
and accessing treatment. The tangible power of ART to restore normalcy was 
therefore a critical lever in decisions to test for HIV (Box 1, 3d).  
 
DISCUSSION 
Our analysis revealed that the overwhelming majority of participants deferred 
testing until they became symptomatic, many with symptoms that were indicative of 
HIV and with CD4 counts below the treatment threshold at the time. Delaying HIV-
testing until symptomatic is well-reported in the literature from sub-Saharan Africa, 
including South Africa (Daftary et al., 2007; Meiberg, Bos, Onya, & Schaalma, 2008; 
Musheke et al., 2013).  What is particularly concerning about the delays in testing 
reported here is that data were collected after a population-level campaign to 
encourage HIV-testing.    
 
By utilizing the concept of diagnostic itineraries, we have demonstrated that 
symptomatic participants sought diagnostic recourse in a variety of arenas within a 
pluralistic healthcare system. This “therapeutic eclecticism” (Scorgie, 2007), common 
in many settings, has been well-described among patients living with HIV in South 
Africa (Moshabela et al., 2011; Scorgie, 2007), reflecting historical processes and 
“local logics” about health (Scorgie, 2007). However, this eclecticism often resulted 
in delayed diagnosis of HIV, something described in one of the only other studies to 
map pathways to HIV care in South Africa, conducted in 2006-2007 in rural 
Mpumalaanga (Moshabela et al., 2011).  
 Also similar to findings in the Mpumalaanga study, use of the folk sector was rarely 
reported. Instead, participants mainly drew upon the professional sector when ill.  
However, despite the predominance of the professional sector in our study, only a 
small proportion of initial contacts with clinics and hospitals resulted in an HIV test. 
Many participants stated the importance of “knowing your status,” echoing the 
broader discourse of public health messages about HIV testing. Conversely, 
reluctance to test for HIV remained relatively common, revealing a discrepancy 
between beliefs about HIV testing and testing behaviors. We identified significant 
barriers to testing such as low perception of HIV risk and fears about an HIV-positive 
diagnosis in the physical, psychological, and social domains. This includes the 
enduring association between HIV and death, and anticipated HIV-related stigma 
and discrimination, even in the context of increasing availability of ART.  
 
Despite these fears, the increasing availability of ART and its potential to restore 
health and normalcy emerged as an important motivating factor to seek HIV testing.  
The optimism fostered by ART roll-out across sub-Saharan Africa is acknowledged as 
an important lever in HIV testing throughout the region (Balcha, Jeppsson, & Bekele, 
2011; Daftary et al., 2007; Jurgensen, Tuba, Fylkesnes, & Blystad, 2012; Ntsepe et al., 
2014; Phakathi et al., 2011; Roura et al., 2009).  Furthermore, support and 
encouragement to test by family, peers and healthcare professionals (once a test 
had been proposed) was invaluable. 
 
This study focuses on patients attending primary healthcare clinics in KwaZulu-Natal, 
who by definition have accessed testing services within the professional healthcare 
sector. This may explain in part why structural factors such as transport, travel time, 
and work-related responsibilities did not emerge as important testing barriers; the 
study may therefore not reflect the experiences of those who have limited access to 
the professional healthcare sector, or indeed those who prefer to seek help within 
other healthcare sectors. Diagnostic itineraries were recalled retrospectively, which 
may have led to some inaccuracies, although this is likely to have been mitigated by 
interviewing all participants within 30 days of their first HIV-positive test. Another 
limitation is that we were unable to quantify delays in testing due to lack of data on 
timescales.   
 
However, we present one of few qualitative studies of individuals’ HIV-testing 
decision-making since the 2010-2011 South African HCT campaign. Although there 
has been continued innovation in HIV testing in the region and further expansion of 
ART eligibility, this study provides insights into contextual factors that shape HIV-
testing decision-making.  This is especially pertinent at this critical juncture in the 
South African response to the HIV epidemic with the implementation of universal 
testing and treatment (UTT). 
 
Our findings of barriers to testing at both an individual and community level have 
been borne out by more recent qualitative data from a test and treat trial in Eastern 
Africa (Camlin et al., 2016). Consequently, multi-level approaches to HIV testing such 
as a recently-reported mobile and home-based testing campaign focusing on a 
variety of medical conditions (Chamie et al., 2016), as well as mass media campaigns, 
community-based testing, and self-testing (Bolsewicz, Vallely, Debattista, Whittaker, 
& Fitzgerald, 2014; Hensen, Taoka, Lewis, Weiss, & Hargreaves, 2014; Musheke et 
al., 2013; Sharma, Ying, Tarr, & Barnabas, 2015) are likely to be most effective. 
Furthermore, efforts to normalize testing must directly address the widespread 
belief that HIV testing is only indicated when symptomatic.  
 
Importantly, our study revealed missed opportunities for HIV testing within hospitals 
and clinics, highlighting the importance of developing interventions to support the 
national policy of provider-initiated testing. Finally, providers outside the 
professional sector, such as local chemists (who were the second most commonly-
accessed service in our study), may be an under-utilized resource to promote HCT, 
and continued efforts to engage these practitioners may reduce late diagnosis of HIV 
(George, Chitindingu, & Gow, 2013; Moshabela et al., 2016).   
 
In conclusion, we have demonstrated that despite a high profile national HIV testing 
campaign, delayed HIV testing in KwaZulu-Natal remained common. Testing delays 
were due to a complex interplay between medical pluralism, low perception of HIV 
risk, fears about a positive diagnosis, and persistent concerns about HIV-related 
stigma and discrimination. Continued implementation of multi-level interventions to 
facilitate early and routine HIV testing is of utmost importance in this area of high 
HIV prevalence and late diagnosis, especially in an era of UTT. Without this, HIV 
testing will remain a diagnostic tool rather than a tool for prevention.  
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